Call for action: expanding global access to hereditary cancer genetic testing

Author:

Bychkovsky Brittany,Rana Huma Q,Ademuyiwa Foluso,Plichta Jennifer,Anderson Karen,Nogueira-Rodrigues Angélica,Santa-Maria Cesar A,Coffman Lan G,Marquez Carol,Das Arunangshu,Taghian Alphonse,Koeller Diane R,Sandoval Renata L,Park Ben Ho,Dizon Don S

Publisher

Elsevier BV

Subject

Oncology

Reference9 articles.

1. A randomized controlled trial of video-education or in-person genetic counseling for men with prostate cancer (ProGen);Rana;J Clin Oncol,2020

2. Concerns about cancer risk and experiences with genetic testing in a diverse population of patients with breast cancer;Jagsi;J Clin Oncol,2015

3. Recommendations for advancing the diagnosis and management of hereditary breast and ovarian cancer in Brazil;Achatz;JCO Glob Oncol,2020

4. Planning cancer control in Latin America and the Caribbean;Goss;Lancet Oncol,2013

5. Closing gaps in cancer screening: connecting people, communities, and systems to improve equity and access. A report from the President's Cancer Panel to the President of the United States,2022

Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3